| TRCK | Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE) | 03/03 08:03 |
| IMUX | Immunic to present at healthcare investor conferences in March | 03/03 08:02 |
| TISI | Clear Channel Outdoor, Footballco Team Up to Bring Global Soccer Content to Digital Screens Across the U.S. | 03/03 08:02 |
| RNWF | Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Highlights Strategic Imperative for Domestic Fusion Energy as Escalating U.S.–Iran Conflict Raises Energy Security Risks | 03/03 08:01 |
| OSW | Bear of the Day: OneSpaWorld (OSW) | 03/03 08:01 |
| IAG | Bull of the Day: IAMGOLD (IAG) | 03/03 08:01 |
| RNAZ | TransCode Secures Exclusive, Worldwide, Fully Paid-Up Royalty-Free License to Develop and Commercialize a Next-Generation Oncolytic Immunotherapy Platform in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients | 03/03 08:01 |
| VNDA | Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years | 03/03 08:01 |
| SYK | Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting | 03/03 08:00 |
| BYRN | Byrna Technologies Announces CEO Transition | 03/03 08:00 |
| ORCL | Oracle Financial Services Named a Top Vendor in 2026 Chartis RiskTech 100 Report | 03/03 08:00 |
| INVZ | Innoviz Technologies Expands Partnership with Dataspeed Inc. to Integrate InnovizSMART LiDAR to Drive-by-Wire Platforms | 03/03 08:00 |
| ALLY | KUSTOM ENTERTAINMENT'S DIGITAL ALLY BRAND SECURES MULTI-YEAR BODY CAMERA SUBSCRIPTION WITH PREMIER KANSAS CITY BASED HEALTH SYSTEM | 03/03 08:00 |
| PHRRF | PharmaTher Expands PharmaPatch Delivery Platform into Therapeutic Peptides for the U.S. Market | 03/03 08:00 |
| ELEK | Elektros Inc. Secures U.S. Patent from the U.S. Patent and Trademark Office for Innovative Multi-Port Electric Vehicle Charging Technology | 03/03 08:00 |
| ARQ | Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis | 03/03 08:00 |
| TRUFF | Red Light Holland Reports Third Quarter 2026 Results and Provides Corporate Update | 03/03 08:00 |
| IMDX | Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission | 03/03 08:00 |
| CRT | Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT | 03/03 08:00 |
| EG | Medidata's Experience-based AI Earns Top Luminary Rating in Everest Group 2026 Review | 03/03 08:00 |